Tokio Marine Asset Management Co. Ltd. Buys 2,472 Shares of CVS Health Co. (NYSE:CVS)

Tokio Marine Asset Management Co. Ltd. boosted its position in CVS Health Co. (NYSE:CVS) by 7.9% in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 33,660 shares of the pharmacy operator’s stock after purchasing an additional 2,472 shares during the quarter. Tokio Marine Asset Management Co. Ltd.’s holdings in CVS Health were worth $2,117,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of CVS. Livelsberger Financial Advisory purchased a new stake in CVS Health during the third quarter valued at approximately $31,000. Reston Wealth Management LLC purchased a new stake in shares of CVS Health during the 3rd quarter valued at $32,000. First Community Trust NA boosted its position in shares of CVS Health by 116.2% in the 2nd quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock worth $33,000 after purchasing an additional 302 shares in the last quarter. Kathleen S. Wright Associates Inc. acquired a new position in CVS Health during the 3rd quarter valued at about $33,000. Finally, ORG Partners LLC boosted its holdings in CVS Health by 11,840.0% in the second quarter. ORG Partners LLC now owns 597 shares of the pharmacy operator’s stock worth $35,000 after acquiring an additional 592 shares in the last quarter. 80.66% of the stock is owned by hedge funds and other institutional investors.

CVS Health Trading Up 1.5 %

Shares of CVS stock opened at $55.11 on Friday. CVS Health Co. has a twelve month low of $52.77 and a twelve month high of $83.25. The stock has a market cap of $69.35 billion, a price-to-earnings ratio of 13.99, a PEG ratio of 0.93 and a beta of 0.55. The company’s 50-day moving average price is $59.41 and its 200-day moving average price is $58.79. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, beating the consensus estimate of $1.08 by $0.01. The business had revenue of $95.43 billion during the quarter, compared to analysts’ expectations of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The business’s revenue for the quarter was up 6.3% on a year-over-year basis. During the same quarter in the prior year, the company posted $2.21 EPS. As a group, equities analysts predict that CVS Health Co. will post 5.48 earnings per share for the current year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, November 1st. Stockholders of record on Monday, October 21st were paid a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 4.83%. The ex-dividend date of this dividend was Monday, October 21st. CVS Health’s dividend payout ratio (DPR) is presently 67.51%.

Wall Street Analyst Weigh In

Several equities analysts recently commented on CVS shares. TD Cowen raised shares of CVS Health from a “hold” rating to a “buy” rating and increased their price objective for the company from $59.00 to $85.00 in a research report on Friday, October 4th. UBS Group boosted their price objective on CVS Health from $60.00 to $62.00 and gave the company a “neutral” rating in a report on Thursday, November 7th. Barclays reduced their price target on CVS Health from $75.00 to $71.00 and set an “overweight” rating for the company in a research report on Thursday, November 7th. Truist Financial upped their price objective on shares of CVS Health from $66.00 to $76.00 and gave the stock a “buy” rating in a research report on Friday, October 11th. Finally, Mizuho reduced their target price on CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a research note on Thursday, October 24th. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and twelve have given a buy rating to the company’s stock. Based on data from MarketBeat.com, CVS Health presently has a consensus rating of “Moderate Buy” and a consensus target price of $73.00.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.